glp-1 lawsuit Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Judicial Panel Authorizes New GLP-1

Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar

However, innovations in drug delivery have sparked interest in alternatives like the GLP-1 patch

According to the 2024 World Obesity Report, the global prevalence of obesity is steadily increasing, with projections indicating that by 2035, over half of the world's population will be classified as overweight [1]

We also address current barriers to implementation and evidence-based use, ongoing clinical trials, and future directions, including combination therapies that may enhance efficacy and patient outcomes.

The preliminary data on the effect of GLP-1 RAson asthma in patients with diabetes are promising and merit further trials and research studies.

COA included